Pfizer and Moderna are FOIA Targets | Law Street Media
The impending expiration of the PREP Act’s legal immunity for Pfizer and Moderna marks a significant shift in vaccine liability, transitioning injured claimants from a nearly ineffective federal compensation program to the open court system. This change invites scrutiny of how legal mechanisms adapt when emergency protections lapse, highlighting the tension between rapid public health intervention and long-term accountability. For open data enthusiasts, this scenario underscores the critical role of transparency tools in predicting legal and market impacts before they fully materialize. Law firms and media organizations are currently leveraging Freedom of Information Act requests to gather granular safety data, such as lot numbers and internal communications, preparing for potential mass litigation. This proactive data collection demonstrates how FOIA requests serve as early warning systems for organizational risk and reputation management. The sheer volume and specificity of these demands reveal a strategic use of public records to build cases or shape narratives, illustrating the practical application of open government data in competitive intelligence and legal research. This article is relevant to open data because it exemplifies the power of FOIA databases in monitoring corporate and governmental behavior. By tracking these requests, analysts can identify emerging trends in accountability and transparency, showing how accessible public records facilitate both corporate due diligence and public oversight. The case highlights that open data is not merely archival but a dynamic tool for anticipating shifts in legal landscapes and ensuring that critical health information remains subject to public scrutiny even after emergency measures end.
Source: lawstreetmedia.comPublished on 2023-04-07